{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:50:45Z","timestamp":1777535445755,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Bjarne Saxhof Fund"},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"crossref","award":["R165-2013-16034"],"award-info":[{"award-number":["R165-2013-16034"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.expneurol.2018.02.005","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T07:28:43Z","timestamp":1518074923000},"page":"142-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Nigrostriatal proteasome inhibition impairs dopamine neurotransmission and motor function in minipigs"],"prefix":"10.1016","volume":"303","author":[{"given":"Thea P.","family":"Lillethorup","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas N.","family":"Glud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aage K.O.","family":"Alstrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trine W.","family":"Mikkelsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik H.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1933-3035","authenticated-orcid":false,"given":"Hamed","family":"Zaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris J.","family":"Doudet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Christian H.","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariusz","family":"Orlowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7371-8713","authenticated-orcid":false,"given":"Anne M.","family":"Landau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2018.02.005_bb0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0006-8993(90)91318-B","article-title":"Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats","volume":"525","author":"Abercrombie","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0010","series-title":"Anaesthesia and Analgesia in Ellegaard G\u00f6ttingen Minipigs","author":"Alstrup","year":"2010"},{"issue":"2","key":"10.1016\/j.expneurol.2018.02.005_bb0015","first-page":"1","article-title":"PET radioligand injection for pig neuroimaging","volume":"44","author":"Alstrup","year":"2018","journal-title":"Scand. J. Lab. Anim. Sci."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0020","doi-asserted-by":"crossref","first-page":"8189","DOI":"10.1523\/JNEUROSCI.2218-08.2008","article-title":"Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies","volume":"28","author":"Bedford","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fnbeh.2015.00068","article-title":"Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated alpha-synuclein","volume":"9","author":"Bentea","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3233\/JPD-160921","article-title":"The proteasome inhibition model of Parkinson's disease","volume":"7","author":"Bentea","year":"2017","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0035","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.expneurol.2004.08.021","article-title":"Ubiquitin-proteasome system and Parkinson's diseases","volume":"191","author":"Betarbet","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jneumeth.2009.06.019","article-title":"MRI-guided stereotaxic targeting in pigs based on a stereotaxic localizer box fitted with an isocentric frame and use of SurgiPlan computer-planning software","volume":"183","author":"Bjarkam","year":"2009","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.expneurol.2018.02.005_bb0045","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s00429-016-1327-5","article-title":"The telencephalon of the Gottingen minipig, cytoarchitecture and cortical surface anatomy","volume":"222","author":"Bjarkam","year":"2017","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0050","first-page":"55511","article-title":"Exposure of the pig CNS for histological analysis: a manual for decapitation, skull opening, and brain removal","volume":"122","author":"Bjarkam","year":"2017","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0055","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/sj.jcbfm.9600276","article-title":"Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease","volume":"26","author":"Bohnen","year":"2006","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0060","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ana.23939","article-title":"Validation of midbrain positron emission tomography measures for nigrostriatal neurons in macaques","volume":"74","author":"Brown","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-2-14","article-title":"Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition","volume":"2","author":"Croisier","year":"2005","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2018.02.005_bb0070","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy","volume":"305","author":"Cuervo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2018.02.005_bb0075","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/brain\/awg172","article-title":"Parkinson's disease: piecing together a genetic jigsaw","volume":"126","author":"Dekker","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2018.02.005_bb0080","doi-asserted-by":"crossref","first-page":"7273","DOI":"10.1074\/jbc.271.13.7273","article-title":"Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin beta-lactone","volume":"271","author":"Dick","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0085","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1074\/jbc.272.1.182","article-title":"Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells","volume":"272","author":"Dick","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0090","doi-asserted-by":"crossref","first-page":"14508","DOI":"10.1523\/JNEUROSCI.1560-11.2011","article-title":"Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of alpha-synuclein","volume":"31","author":"Ebrahimi-Fakhari","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0095","first-page":"2652","article-title":"Basic surgical techniques in the Gottingen minipig: intubation, bladder catheterization, femoral vessel catheterization, and transcardial perfusion","volume":"52","author":"Ettrup","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0100","doi-asserted-by":"crossref","first-page":"508","DOI":"10.55782\/ane-2011-1867","article-title":"Direct MRI-guided stereotaxic viral mediated gene transfer of alpha-synuclein in the Gottingen minipig CNS","volume":"71","author":"Glud","year":"2011","journal-title":"Acta Neurobiol. Exp. (Wars)"},{"key":"10.1016\/j.expneurol.2018.02.005_bb0105","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jneumeth.2017.04.017","article-title":"A fiducial skull marker for precise MRI-based stereotaxic surgery in large animal models","volume":"285","author":"Glud","year":"2017","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.expneurol.2018.02.005_bb0110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neulet.2015.12.052","article-title":"Associated degeneration of ventral tegmental area dopaminergic neurons in the rat nigrostriatal lactacystin model of parkinsonism and their neuroprotection by valproate","volume":"614","author":"Harrison","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0115","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0120","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/jamaneurol.2014.290","article-title":"Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography","volume":"71","author":"Hsiao","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0125","first-page":"1517","article-title":"Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease","volume":"148","author":"Iwatsubo","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0130","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1742-7843.2011.00782.x","article-title":"Unpredictable rotational responses to L-dopa in the rat model of Parkinson's disease: the role of L-dopa pharmacokinetics and striatal dopamine depletion","volume":"110","author":"Kaariainen","year":"2012","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nucmedbio.2009.08.013","article-title":"In vivo [11C]dihydrotetrabenazine binding in rat striatum: sensitivity to dopamine concentrations","volume":"37","author":"Kilbourn","year":"2010","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0140","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2018.02.005_bb0145","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1097\/00004647-199611000-00025","article-title":"Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter","volume":"16","author":"Koeppe","year":"1996","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbr.2013.12.019","article-title":"Chronic L-DOPA treatment attenuates behavioral and biochemical deficits induced by unilateral lactacystin administration into the rat substantia nigra","volume":"261","author":"Konieczny","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0155","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bbr.2015.01.043","article-title":"Decreased behavioral response to intranigrally administered GABAA agonist muscimol in the lactacystin model of Parkinson's disease may result from partial lesion of nigral non-dopamine neurons: comparison to the classical neurotoxin 6-OHDA","volume":"283","author":"Konieczny","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0160","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuroscience.2016.02.072","article-title":"Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats","volume":"324","author":"Konieczny","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2018.02.005_bb0165","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ana.20935","article-title":"Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys","volume":"60","author":"Kordower","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0170","article-title":"Elevated dopamine D1 receptor availability in striatum of Gottingen minipigs after electroconvulsive therapy","author":"Landau","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0175","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4","article-title":"In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease","volume":"47","author":"Lee","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0180","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/26652","article-title":"The ubiquitin pathway in Parkinson's disease","volume":"395","author":"Leroy","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2018.02.005_bb0185","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/NEN.0b013e318186de64","article-title":"C-Jun N-terminal kinase mediates lactacystin-induced dopamine neuron degeneration","volume":"67","author":"Li","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0190","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00004647-199609000-00008","article-title":"Distribution volume ratios without blood sampling from graphical analysis of PET data","volume":"16","author":"Logan","year":"1996","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0195","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuint.2011.03.013","article-title":"Different effects of intranigral and intrastriatal administration of the proteasome inhibitor lactacystin on typical neurochemical and histological markers of Parkinson's disease in rats","volume":"58","author":"Lorenc-Koci","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0200","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/path.1711550105","volume":"155","author":"Lowe","year":"1988","journal-title":"J. Pathol."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0205","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.expneurol.2013.03.021","article-title":"Direct intranigral administration of an ubiquitin proteasome system inhibitor in rat: behavior, positron emission tomography, immunohistochemistry","volume":"247","author":"Mackey","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0210","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainres.2007.06.076","article-title":"Systemic administration of a proteasome inhibitor does not cause nigrostriatal dopamine degeneration","volume":"1168","author":"Mathur","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0215","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","article-title":"Glial reactions in Parkinson's disease","volume":"23","author":"McGeer","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0220","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ana.10728","article-title":"Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration","volume":"54","author":"McGeer","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0225","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","article-title":"Proteasomal function is impaired in substantia nigra in Parkinson's disease","volume":"297","author":"McNaught","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0230","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1097\/00001756-200208070-00018","article-title":"Proteasome inhibition causes nigral degeneration with inclusion bodies in rats","volume":"13","author":"McNaught","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.expneurol.2018.02.005_bb0235","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ana.20186","article-title":"Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease","volume":"56","author":"McNaught","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0240","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/syn.21883","article-title":"Interpreting DTBZ binding data in rodent: inherent variability and compensation","volume":"70","author":"Mejias","year":"2016","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2018.02.005_bb0245","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0892-0362(98)00037-3","article-title":"MPTP-induced Parkinsonism in minipigs: a behavioral, biochemical, and histological study","volume":"21","author":"Mikkelsen","year":"1999","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0250","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neulet.2005.01.024","article-title":"Retrograde dopaminergic neuron degeneration following intrastriatal proteasome inhibition","volume":"380","author":"Miwa","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0255","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000202972","article-title":"Nigral degeneration with inclusion body formation and behavioral changes in rats after proteasomal inhibition","volume":"87","author":"Niu","year":"2009","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0260","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.1038\/s41598-017-06724-9","article-title":"Early synaptic dysfunction induced by alpha-synuclein in a rat model of Parkinson's disease","volume":"7","author":"Phan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0265","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00429-013-0669-5","article-title":"An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease","volume":"220","author":"Pienaar","year":"2015","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0270","doi-asserted-by":"crossref","first-page":"18666","DOI":"10.1073\/pnas.1105725108","article-title":"Alpha-Synuclein fate is determined by USP9X-regulated monoubiquitination","volume":"108","author":"Rott","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0275","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1007\/s00221-017-4962-z","article-title":"Nigral injection of a proteasomal inhibitor, lactacystin, induces widespread glial cell activation and shows various phenotypes of Parkinson's disease in young and adult mouse","volume":"235","author":"Savolainen","year":"2017","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0280","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.20934","article-title":"Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neurons","volume":"60","author":"Schapira","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0285","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1471-4159.1988.tb10583.x","article-title":"[3H]dihydrotetrabenazine, a new in vitro monoaminergic probe for human brain","volume":"50","author":"Scherman","year":"1988","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0290","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.expneurol.2018.02.005_bb0295","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s11307-006-0051-6","article-title":"Evaluation of the integrity of the dopamine system in a rodent model of Parkinson's disease: small animal positron emission tomography compared to behavioral assessment and autoradiography","volume":"8","author":"Strome","year":"2006","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0300","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1111\/ejn.12660","article-title":"Selective increase of in vivo firing frequencies in DA SN neurons after proteasome inhibition in the ventral midbrain","volume":"40","author":"Subramaniam","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0305","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/syn.1089","article-title":"Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers","volume":"41","author":"Suzuki","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2018.02.005_bb0310","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0014-5793(01)03115-5","article-title":"Alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome","volume":"509","author":"Tofaris","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0315","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/syn.20573","article-title":"Dopamine modulating drugs influence striatal (+)-[11C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration","volume":"62","author":"Tong","year":"2008","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2018.02.005_bb0320","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0014-2999(95)00594-3","article-title":"The vesicular monoamine transporter is not regulated by dopaminergic drug treatments","volume":"294","author":"Vander Borght","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017269","article-title":"Evolution of extra-nigral damage predicts behavioural deficits in a rat proteasome inhibitor model of Parkinson's disease","volume":"6","author":"Vernon","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2018.02.005_bb0330","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1146\/annurev.biochem.68.1.1015","article-title":"The 26S proteasome: a molecular machine designed for controlled proteolysis","volume":"68","author":"Voges","year":"1999","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.expneurol.2018.02.005_bb0335","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1006\/nimg.2001.0910","article-title":"MR-based statistical atlas of the Gottingen minipig brain","volume":"14","author":"Watanabe","year":"2001","journal-title":"NeuroImage"},{"key":"10.1016\/j.expneurol.2018.02.005_bb0340","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1471-4159.2010.06914.x","article-title":"Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease","volume":"115","author":"Xie","year":"2010","journal-title":"J. Neurochem."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488618300451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488618300451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T01:55:33Z","timestamp":1719798933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488618300451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":68,"alternative-id":["S0014488618300451"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2018.02.005","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nigrostriatal proteasome inhibition impairs dopamine neurotransmission and motor function in minipigs","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2018.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}